APIMEDS PHARMACEUTICALS US Stock Price, News & Analysis
APUS
NYSE
Company Description
Welcome to the overview page for APIMEDS PHARMACEUTICALS US (APUS), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$2.90
0.00%
0.00
Last updated: December 1, 2025 at 09:01
31.82 %
Performance 1 year
$27.5M
12.6M
Latest News
SEC Filings
Financial Highlights
$0
Revenue (TTM)
-$2,662,193
Net Income (TTM)
-$0.26
-$3,361,096
Operating Cash Flow
12.79
-$2,663,904
Upcoming Events
JAN
01
January 1, 2026 - March 31, 2026
Corporate
ai² Futures Lab launch
Program launch with University of Oregon’s Lundquist College for ai² Futures Lab mentoring
APR
01
April 1, 2026
Corporate
ai² Futures Lab expansion
Collaboration program with University of Idaho College of Business and Economics
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of APIMEDS PHARMACEUTICALS US (APUS)?
The current stock price of APIMEDS PHARMACEUTICALS US (APUS) is $2.9 as of November 28, 2025.
What is the market cap of APIMEDS PHARMACEUTICALS US (APUS)?
The market cap of APIMEDS PHARMACEUTICALS US (APUS) is approximately 27.5M. Learn more about what market capitalization means .
What is the revenue (TTM) of APIMEDS PHARMACEUTICALS US (APUS) stock?
The trailing twelve months (TTM) revenue of APIMEDS PHARMACEUTICALS US (APUS) is $0.
What is the net income of APIMEDS PHARMACEUTICALS US (APUS)?
The trailing twelve months (TTM) net income of APIMEDS PHARMACEUTICALS US (APUS) is -$2,662,193.
What is the earnings per share (EPS) of APIMEDS PHARMACEUTICALS US (APUS)?
The diluted earnings per share (EPS) of APIMEDS PHARMACEUTICALS US (APUS) is -$0.26 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of APIMEDS PHARMACEUTICALS US (APUS)?
The operating cash flow of APIMEDS PHARMACEUTICALS US (APUS) is -$3,361,096. Learn about cash flow.
What is the current ratio of APIMEDS PHARMACEUTICALS US (APUS)?
The current ratio of APIMEDS PHARMACEUTICALS US (APUS) is 12.79, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of APIMEDS PHARMACEUTICALS US (APUS)?
The operating income of APIMEDS PHARMACEUTICALS US (APUS) is -$2,663,904. Learn about operating income.